AAP
SAGE
Aristotle Atlantic Partners’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-197,626
| Closed | -$9.29M | – | 104 |
|
|
2023
Q2 | $9.29M | Buy |
197,626
+41,107
| +26% | +$1.93M | 0.35% | 61 |
|
|
2023
Q1 | $6.57M | Buy |
156,519
+422
| +0.3% | +$17.7K | 0.34% | 66 |
|
|
2022
Q4 | $5.95M | Sell |
156,097
-381
| -0.2% | -$14.5K | 0.33% | 67 |
|
|
2022
Q3 | $6.13M | Buy |
156,478
+1,360
| +0.9% | +$53.3K | 0.37% | 66 |
|
|
2022
Q2 | $5.01M | Buy |
155,118
+3,015
| +2% | +$97.4K | 0.39% | 61 |
|
|
2022
Q1 | $5.04M | Buy |
152,103
+1,206
| +0.8% | +$39.9K | 0.31% | 68 |
|
|
2021
Q4 | $6.42M | Sell |
150,897
-10,393
| -6% | -$442K | 0.37% | 63 |
|
|
2021
Q3 | $7.15M | Buy |
161,290
+85
| +0.1% | +$3.77K | 0.47% | 46 |
|
|
2021
Q2 | $9.16M | Buy |
161,205
+144
| +0.1% | +$8.18K | 0.6% | 40 |
|
|
2021
Q1 | $12.1M | Buy |
161,061
+256
| +0.2% | +$19.2K | 0.88% | 35 |
|
|
2020
Q4 | $13.9M | Buy |
160,805
+3,535
| +2% | +$306K | 1.07% | 34 |
|
|
2020
Q3 | $9.61M | Buy |
157,270
+86,887
| +123% | +$5.31M | 0.85% | 34 |
|
|
2020
Q2 | $2.93M | Buy |
70,383
+15,559
| +28% | +$647K | 0.28% | 48 |
|
|
2020
Q1 | $1.57M | Sell |
54,824
-12,789
| -19% | -$367K | 0.24% | 54 |
|
|
2019
Q4 | $4.88M | Buy |
67,613
+53,603
| +383% | +$3.87M | 0.62% | 39 |
|
|
2019
Q3 | $1.97M | Buy |
14,010
+107
| +0.8% | +$15K | 0.57% | 33 |
|
|
2019
Q2 | $2.55M | Sell |
13,903
-46
| -0.3% | -$8.42K | 0.74% | 26 |
|
|
2019
Q1 | $2.22M | Buy |
13,949
+2,033
| +17% | +$323K | 0.67% | 30 |
|
|
2018
Q4 | $1.14M | Buy |
11,916
+3,216
| +37% | +$308K | 0.4% | 41 |
|
|
2018
Q3 | $961K | Hold |
8,700
| – | – | 0.59% | 34 |
|
|
2018
Q2 | $1.36M | Buy |
+8,700
| New | +$1.36M | 0.47% | 34 |
|